Neuroprotection by mefenamic acid against d-serine: Involvement of oxidative stress, inflammation and apoptosis

Free Radical Research

Volumn 46, Issue 6, 2012, Pages 726-739

  Armagan, Guliz ^a   Turunc, Ezgi ^a   Kanit, Lutfiye ^a   Yalcin, Ayfer ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Apoptosis; D serine; Inflammation; Non steroidal antiinflammatory drugs

Indexed keywords

DEXTRO SERINE; INTERLEUKIN 1BETA; MEFENAMIC ACID; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; HIPPOCAMPUS; INFLAMMATION; LIPID PEROXIDATION; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION; OXIDATIVE STRESS; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; BRAIN; INFLAMMATION; MEFENAMIC ACID; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SERINE;

RATTUS;

EID: 84860744681     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2012.669836     Document Type: Article

References (67)

1. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993;262:689-695. (Pubitemid 23350687)
2. Schulz JB, Henshaw DR, Siwek D, Jenkins BG, Ferrante RJ, Cipolloni PB, et al. Involvement of free radicals in excitotoxicity in vivo. J Neurochem 1995;64:2239-2247.
3. Nakao N, Brundin P. Neurodegeneration and glutamate induced oxidative stress. Prog Brain Res 1998;116:245-263. (Pubitemid 28526939)
4. Mothet JP, Parent AT, Wolosker H, Brady RO Jr, Linden DJ, Ferris CD, et al. D-Serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA 2000;97:4926-4931. (Pubitemid 30238659)
5. Katsuki H, Nonaka M, Shirakawa H, Kume T, Akaike A. Endogenous D-serine is involved in induction of neuronal death by N-methyl-D-aspartate and simulated ischemia in rat cerebrocortical slices. J Pharm Exp Ther 2004;311:836-844. (Pubitemid 39391574)
6. Wolosker H. NMDA receptor regulation by D-serine: new findings and perspectives. Mol Neurobiol 2007;36:152-164. (Pubitemid 351360344)
7. Wu SZ, Bodles AM, Porter MM, Griffin WST, Basile AS, Barger SW, et al. Induction of serine rasemase expression and D-serine release from microglia by amyloid β-peptide. J Neuroinf 2004;1:2.
8. Brito-Moreira J, Paula-Lima AC, Bomfim TR, Oliveira FB, Sep ú lveda FJ, De Mello FG, et al. Aβ oligomers induce glutamate release from hippocampal neurons. Curr Alzheimer Res 2011;8:552-562.
9. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994;330:613-622.
10. Ho L, Purohit D, Haroutunian V, Luterman JD, Willis F, Naslund J, et al. Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease. Arch Neurol 2001;58:487-492. (Pubitemid 32217467)
11. Hoozemans JJ, Rozemuller AJ, Janssen I, De Groot CJ, Veerhuis R, Eikelenboom P, et al. Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain. Acta Neuropathol 2001;101:2-8. (Pubitemid 32124493)
12. Andreasson KI, Savonenko A, Vidensky S, Goellner JJ, Zhang Y, Shaffer A, Kaufmann WE, Worley P, FIsakson P, Markowska AL, et al. Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice. J Neurosci 2001;21:8198-8209. (Pubitemid 32952775)
13. Asanuma M, Nishibayashi-Asanuma S, Miyazzaki I, Kohno M, Ogawa N. Neuroprotective effects of non-steroidal antiinflammatory drugs by direct scavenging of nitric oxide radicals. J Neurochem 2001;76:1895-1904. (Pubitemid 32221130)
14. Khansari PS, Halliwell RF. Evidence for neuroprotection by the fenamate NSAID, mefenamic acid. Neurochem Int 2009;55: 683-688.
15. Armagan G, Kanit L, Yalcin A. D-Serine induces oxidative stres in rat brain. Drug Chem Toxicol 2011;34:129-138.
16. Armagan G, Kanit L, Yalcin A. Effects of non-steroidal antiinflammatory drugs on D-serine-induced oxidative stress in vitro. Drug Chem Toxicol. doi:10.3109/01480545.2011.633086.
17. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the folin-phenol reagent. J Biol Chem 1951;193:265-375.
18. Driver AS, Kodavanti PRS, Mundy WR. Age-related changes in reactive oxygen species production in rat brain homogenates. Neurotox Teratol 2000;22:175-181. (Pubitemid 30176073)
19. Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 1990;186: 421-431. (Pubitemid 20279983)
20. Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay, Methods Enzymol 1994;233:357-363.
21. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 1993;15:532-537. (Pubitemid 23270488)
22. Yalcin A, Kanit L, Sozmen EY. Altered gene expressions in the rat hippocampus after kainic acid with or without melatonin pre-treatment. Neurosci Lett 2004;359;65-68. (Pubitemid 38446640)
23. Rozen S, Skaletsky HJ. Primers on the WWW for general users and for biologist programmers. Methods Mol Biol 2000;132: 365-386.
24. Livak KJ, Schmittengen TD. Analysis of relative gene expression data using realtime quantitative PCR and the 2-δδCT method. Methods 2001;25:402-408. (Pubitemid 34164012)
25. Levine RL. Carbonyl modified proteins in cellular regulation, aging, and disease. Free Radic Biol Med 2002;2:790-796. (Pubitemid 34439249)
26. Rosi S, Vazdarjanova A, Ramirez-Amaya V, Worley PF, Barnes CA, Wenk GL, et al. Memantine protects against LPS-induced neuroinflammation, restores behaviorally-induced gene expression and spatial learning in the rat. Neuroscience 2006;142:1303-1315. (Pubitemid 44636069)
27. Tilleux S, Hermans E. Neuroinflammation and regulation of glial glutamate uptake in neurological disorders. J Neurosci Res 2007;85:2059-2070. (Pubitemid 47172138)
28. Chang YC, Kim HW, Rapoport SI, Rao JS. Chronic NMDA administration increases neuroinflammatory markers in rat frontal cortex: cross-talk between excitotoxicity and neuroinflammation. Neurochem Res 2008;33:2318-2323.
29. Rao JS, Ertley RN, Rapoport SI, Bazinet RP, Lee HJ. Chronic NMDA administration to rats up-regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein-2. J Neurochem 2007;102:1918-1927. (Pubitemid 47329252)
30. Thommesen L, Sjursen W, Gåsvik K, Hanssen W, Brekke OL, Skatteb ø l L, et al. Selective inhibitors of cytosolic or secretory phospholipase A2 block TNF-induced activation of transcription factor nuclear factor-kappa B and expression of ICAM-1. J Immunol 1998;161:3421-3430.
31. Suyama K, Kabuyama Y, Suzuki S, Kawasaki Y, Suzuki J, Suzuki H, et al. Induction of transcription factor AP-2 by cytokines and prostaglandins in cultured mesangial cells. Am J Nephrol 2001;21:307-314. (Pubitemid 32757315)
32. Pearson VL, Rothwell NJ, Toulmond S. Excitotoxic brain damage in the rat induces interleukin-1beta protein in microglia and astrocytes: correlation with the progression of cell death. Glia 1999;25:311-323. (Pubitemid 29083831)
33. Minami M, Kuraishi Y, Satoh M. Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain. Biochem Biophys Res Commun 1991;176:593-598.
34. Rockwell NJ. Cytokines-killer in the brain? J Physiol 1999; 514:3-17.
35. Hu S, Sheng WS, Ehrlich LC, Peterson PK, Chao CC. Cytokine effects on glutamate uptake by human astrocytes. Neuroimmunomodulation 2000;7:153-159. (Pubitemid 30204821)
36. Russell L, Blaylock MD. Chronic microglial activation and excitotoxicity secondary to excessive immune stimulation: possible factors in Gulf War syndrome and autism. J Am Physici Surgeons 2004;9:46-51.
37. Heyes MP, Saito K, Lackner A, Wiley CA, Achim CL, Markey SP, et al. Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques. FASEB J 1998;12:881-896. (Pubitemid 28294678)
38. Berdichevsky E, Riveros N, Sá nchez-Armá ss S, Orrego F. Kainate, N-methylaspartate and other excitatory amino acids increase calcium influx into rat brain cortex cells in vitro. Neurosci Lett 1983;36:75-80. (Pubitemid 13083403)
39. Arundine M, Tymianski M. Molecular mechanisms of calciumdependent neurodegeneration in excitotoxicity. Cell Calcium 2003;34:325-337. (Pubitemid 37021228)
40. Filbert M, Levine E, Ballough G. Neuroprotection for nerve agent-induced brain damage by blocking delayed calcium overload: a review. J Med CBR Def 2004;3:1-21.
41. Zhivotovsky B, Orrenius S. Cell death mechanisms: cross-talk and role in disease. Exp Cell Res 2010;316:1374-1383.
42. Choi DW. Excitotoxic cell death. J Neurobiol 1992;23: 1261-1276.
43. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 1995;92:7162-7166.
44. Kure S, Tominaga T, Yoshimoto T, Tada K, Narisawa K. Glutamate triggers internucleosomal DNA cleavage in neuronal cells. Biochem Biophys Res Commun 1991;179:39-45.
45. Zhong LT, Kane DJ, Bredesen DE. BCL-2 blocks glutamate toxicity in neural cell lines. Brain Res Mol Brain Res 1993; 19:353-355.
46. Figiel I, Kaczmarek L. Cellular and molecular correlates of glutamate-evoked neuronal programmed cell death in the in vitro cultures of rat hippocampal dentate gyrus. Neurochem Int 1997;31:229-240. (Pubitemid 27267963)
47. Tenneti L, D'Emilia DM, Troy CM, Lipton SA. Role of caspases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons. J Neurochem 1998;71:946-959. (Pubitemid 28390249)
48. Jiang Q, Gu Z, Zhang G, Jing G. N-methyl-D-aspartate receptor activation results in regulation of extracellular signal-regulated kinases by protein kinases and phosphatases in glutamate-induced neuronal apototic-like death. Brain Res 2000;887:285-292. (Pubitemid 32008050)
49. Soto A, DelRaso NJ, Schlager JJ, Chan VT. D-Serine exposure resulted in gene expression changes indicative of activation of fibrogenic pathways and down-regulation of energy metabolism and oxidative stress response. Toxicology 2008;243: 177-192. (Pubitemid 350262787)
50. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, et al. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995;15:961-973.
51. Schelman WR, Andres RD, Sipe KJ, Kang E, Weyhenmeyer JA. Glutamate mediates cell death and increases the Bax to Bcl-2 ratio in a differentiated neuronal cell line. Brain Res Mol Brain Res 2004;128:160-169. (Pubitemid 39201118)
52. Montpied P, Weller M, Paul SM. N-methyl-D-aspartate receptor agonists decrease protooncogene bcl-2 mRNA expression in cultured rat cerebellar granule neurons. Biochem Biophys Res Commun 1993;195:623-629. (Pubitemid 23280462)
53. Hughes PE, Alexi T, Yoshida T, Schreiber SS, Knusel B. Excitotoxic lesion of rat brain with quinolinic acid induces expression of p53 messenger RNA and protein and p53-inducible genes Bax and Gadd-45 in brain areas showing DNA fragmentation. Neuroscience 1996;74:1143-1160. (Pubitemid 26313357)
54. Chen J, Marsh T, Zhang JS, Graham SH. Expression of cyclooxygenase 2 in rat brain following kainate treatment. Neuroreport 1995;6:245-248.
55. Adams J, Collaco-Moraes Y, de Belleroche J. Cyclooxygenase 2 induction in cerebral cortex: an intracellular response to synaptic excitation. J Neurochem 1996;66:6-13. (Pubitemid 26010758)
56. Miettinen S, Fusco FR, Yrjänheikki J, Keinä nen R, Hirvonen T, Roivainen R, et al. Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic acid-receptors and phospholipase A2. Proc Natl Acad Sci USA 1997;94:6500-6505. (Pubitemid 27270714)
57. Hewett SJ, Uliasz TF, Vidwans AS, Hewett JA. Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture. J Pharmacol Exp Ther 2000;293:417-425. (Pubitemid 30244090)
58. Strauss KI, Marini AM. Cyclooxygenase-2 inhibition protects cultured cerebellar granule neurons from glutamate-mediated cell death. J Neurotrauma 2002;19:627-638. (Pubitemid 34587305)
59. Strauss KI. Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain. Brain Behav Immun 2008;22:285-298. (Pubitemid 351187774)
60. Ramos CL, Pou S, Rosen GM. Effect of anti-inflammatory drugs on myeloperoxidase-dependent hydroxyl radical generation by human neutrophils. Biochem Pharmacol 1993;49: 1079-1084.
61. Halliwell RF, Thomas P, Patten D, James CH, Martinez-Torres A, Miledi R, et al. Subunit-selective modulation of GABAA receptors by the non-steroidal anti-inflammatory agent, mefenamic acid. Eur J Neurosci 1999;11:2897-2905. (Pubitemid 29364206)
62. Coyne L, Su J, Patten D, Halliwell RF. Characterization of the interaction between fenamates and hippocampal neuron GABA(A) receptors. Neurochem Int 2007;51:440-446. (Pubitemid 47503467)
63. Leipnitz G, da Silva Lde B, Fernandes CG, Seminotti B, Amaral AU, Dutra-Filho CS, et al. D-Serine administration provokes lipid oxidation and decreases the antioxidant defenses in rat striatum. Int J Dev Neurosci 2010;28:297-301.
64. Ikonomidou-Turski C, Cavalheiro EA, Turski L, Bortolotto ZA, Kleinrok Z, Calderazzo-Filho LS, et al. Differential effects of non-steroidal anti-inflammatory drugs on seizures produced by pilocarpine in rats. Brain Res 1988;462:275-285.
65. Camins A, Sureda FX, Junyent F, Verdaguer E, Folch J, Beas-Zarate C, et al. An overview of investigational antiapoptotic drugs with potential application for the treatment of neurodegenerative disorders. Expert Opin Investig Drugs 2010;19:587-604.
66. 2+ overload underlies Abeta oligomers neurotoxicity providing an unexpected mechanism of neuroprotection by NSAIDs. PLoS One 2008;3:e2718.
67. Woo DH, Han IS, Jung G. Mefenamic acid-induced apoptosis in human liver cancer cell-lines through caspase-3 pathway. Life Sci 2004;75:2439-2449. (Pubitemid 39180048)